Log in to save to my catalogue

O-24: Double-blind, placebo-controlled crossover rotation of the five principal classes of antihyper...

O-24: Double-blind, placebo-controlled crossover rotation of the five principal classes of antihyper...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1026626955

O-24: Double-blind, placebo-controlled crossover rotation of the five principal classes of antihypertensive drugs

About this item

Full title

O-24: Double-blind, placebo-controlled crossover rotation of the five principal classes of antihypertensive drugs

Publisher

Oxford: Oxford University Press

Journal title

American journal of hypertension, 2001-04, Vol.14 (S1), p.10A-11A

Language

English

Formats

Publication information

Publisher

Oxford: Oxford University Press

More information

Scope and Contents

Contents

Outcome studies in hypertension show that achieved BP is more important than choice of initial treatment. Meta-analyses report risk ratios of 1.0 for either calcium blockers (CCB) or ACE inhibitors (ACEi) vs. βblockers (βB) or diuretics (D), but 0.8 for more vs. less intensive reduction in BP by any regimen. We previously reported an open-label rot...

Alternative Titles

Full title

O-24: Double-blind, placebo-controlled crossover rotation of the five principal classes of antihypertensive drugs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1026626955

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1026626955

Other Identifiers

ISSN

0895-7061

E-ISSN

1941-7225

DOI

10.1016/S0895-7061(01)01341-3

How to access this item